MX2016007748A - Composiciones y métodos para tratar, prevenir y diagnosticar cáncer y otros trastornos proliferativos. - Google Patents
Composiciones y métodos para tratar, prevenir y diagnosticar cáncer y otros trastornos proliferativos.Info
- Publication number
- MX2016007748A MX2016007748A MX2016007748A MX2016007748A MX2016007748A MX 2016007748 A MX2016007748 A MX 2016007748A MX 2016007748 A MX2016007748 A MX 2016007748A MX 2016007748 A MX2016007748 A MX 2016007748A MX 2016007748 A MX2016007748 A MX 2016007748A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- compositions
- benzylpropionamide
- dioxol
- benzo
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención proporciona métodos para alterar la función o reducir o ablación de los niveles de las proteínas de Id (inhibidores de la diferenciación) para suprimir la metástasis de las células cancerosas en sujetos mamíferos que presentan cáncer o riesgo elevado de enfermedad metastásica. Los compuestos anti-Id ejemplares incluyen N-(3-(venzo[d] [1,3] dixol-5-il)-3-(2-metoxifenil) propil) -N-bencilpropionamida y enantiómeros aislados de N-(3-(benzo[d] [1, 3] dixol-5-il)-3-(2-metoxifenil) -N-bencilpropionamida. Las composiciones y métodos anti-Id de la invención pueden combinarse con las modalidades de tratamiento anticancerígenas estándar, como cirugía, radiación y quimioterapia. También se proporciona composiciones y métodos para el tratamiento de otros trastornos hiperproliferativos, incluyendo padecimientos angiogénicos patógenos, incluyendo neoangiogénesis asociada con tumor y patologías vasculares oculares incluyendo la degeneración macular relacionada con la edad.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361916116P | 2013-12-13 | 2013-12-13 | |
US201461965776P | 2014-02-06 | 2014-02-06 | |
PCT/US2014/070221 WO2015089495A2 (en) | 2013-12-13 | 2014-12-14 | Compositions and methods for treating, preventing and diagnosing cancer and other proliferative disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2016007748A true MX2016007748A (es) | 2017-07-28 |
Family
ID=53371974
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2016007748A MX2016007748A (es) | 2013-12-13 | 2014-12-14 | Composiciones y métodos para tratar, prevenir y diagnosticar cáncer y otros trastornos proliferativos. |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP3079680A4 (es) |
JP (2) | JP2017506257A (es) |
CN (1) | CN107847470A (es) |
AU (1) | AU2014361814A1 (es) |
MX (1) | MX2016007748A (es) |
WO (1) | WO2015089495A2 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11000548B2 (en) * | 2015-02-18 | 2021-05-11 | Enlivex Therapeutics Ltd | Combination immune therapy and cytokine control therapy for cancer treatment |
CN107708811B (zh) | 2015-04-21 | 2021-04-30 | 恩立夫克治疗有限责任公司 | 治疗性汇集的血液凋亡细胞制剂与其用途 |
JP6884155B2 (ja) | 2016-02-18 | 2021-06-09 | エンリヴェックス セラピューティクス リミテッド | 癌治療のための併用免疫療法及びサイトカイン制御療法 |
LU100900B1 (de) * | 2018-08-10 | 2020-02-17 | Thomas Melchior Homann | Verbindungen zur modulation von a-ketoglutarsäure (2kg)-abhängigen oxygenasen |
EP3760614B8 (en) * | 2019-07-02 | 2022-04-27 | Universität Heidelberg | Chemical inhibitors of id proteins for the treatment of cancer and other diseases |
CN113627763B (zh) * | 2021-07-30 | 2023-12-01 | 厦门大学 | 一种风险量化评估模型建立方法 |
CN114480490A (zh) * | 2021-12-31 | 2022-05-13 | 四川省医学科学院·四川省人民医院 | 一种构建视网膜新生血管性疾病动物模型的方法 |
CN115487358B (zh) * | 2022-08-05 | 2023-05-30 | 核工业四一六医院 | 一种用于软骨组织修复的凝胶复合支架及制备方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8138356B2 (en) * | 2007-10-16 | 2012-03-20 | Angiogeney, Inc. | Chemical inhibitors of inhibitors of differentiation |
US20130171158A1 (en) * | 2010-06-30 | 2013-07-04 | Garvan Institute Of Medical Research | Treatment of abnormalities of glucose metabolism with an antagonist of inhibitor of differentiation 1 |
WO2013025939A2 (en) * | 2011-08-16 | 2013-02-21 | Indiana University Research And Technology Corporation | Compounds and methods for treating cancer by inhibiting the urokinase receptor |
-
2014
- 2014-12-14 AU AU2014361814A patent/AU2014361814A1/en not_active Abandoned
- 2014-12-14 CN CN201480075495.2A patent/CN107847470A/zh active Pending
- 2014-12-14 JP JP2016558543A patent/JP2017506257A/ja active Pending
- 2014-12-14 WO PCT/US2014/070221 patent/WO2015089495A2/en active Application Filing
- 2014-12-14 MX MX2016007748A patent/MX2016007748A/es unknown
- 2014-12-14 EP EP14870415.8A patent/EP3079680A4/en not_active Withdrawn
-
2019
- 2019-09-06 JP JP2019162598A patent/JP2019203028A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP3079680A2 (en) | 2016-10-19 |
WO2015089495A2 (en) | 2015-06-18 |
CN107847470A (zh) | 2018-03-27 |
JP2017506257A (ja) | 2017-03-02 |
AU2014361814A1 (en) | 2016-07-28 |
JP2019203028A (ja) | 2019-11-28 |
WO2015089495A3 (en) | 2015-11-12 |
EP3079680A4 (en) | 2017-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2016007748A (es) | Composiciones y métodos para tratar, prevenir y diagnosticar cáncer y otros trastornos proliferativos. | |
PH12019500521A1 (en) | Pyrazolopyridine derivatives as hpk1 modulators and uses thereof for the treatment of cancer | |
PH12016501809A1 (en) | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders | |
PH12015500181A1 (en) | Atx modulating agents | |
CL2012003604A1 (es) | Compuestos heterociclicos derivados de piridina carboxamida sustituida; proceso de preparacion; composicion farmaceutica; combinacion farmaceutica; uso en el tratamiento de trastornos proliferativos celulares, enfermedad de parkinson, cancer, entre otros. | |
MX2017003246A (es) | Macropinocitosis de anticuerpos anti-cd46 humanos y agentes terapeuticos dirigidos contra el cancer. | |
WO2017096309A8 (en) | Methods of treatment of malignancies | |
EA201391416A1 (ru) | Новые соединения в качестве модуляторов протеинкиназ | |
PH12015501370B1 (en) | Compounds and methods for kinase modulation, and indications therefor | |
EA201691151A1 (ru) | Соединения для лечения пациентов с ros1-мутантными раковыми клетками | |
MX2018003186A (es) | Derivados de 8-[6-[3-(amino)propoxi]-3-piridil]1-isopropilimidazo[ 4,5-c]quinolin-2-ona como moduladores selectivos de la cinasa de la ataxia telangiectasia mutada (atm) para el tratamiento del cancer. | |
EA201790267A1 (ru) | Новые модуляторы киназ | |
CL2012000592A1 (es) | Compuestos derivados de fenoxi o fenil-tieno[3,2-b]piridina, inhibidores de tirosina quinasas; composicion farmaceutica; y su uso en el tratamiento de cancer colorrectal, de pulmon, hematologico, de higado, mama, en retinopatia diabetica, degeneracion macular, glaucoma, psoriasis, diabetes, enfermedades neurodegenerativas, entre otras. | |
EA201291098A1 (ru) | Новые соединения 3,5-дизамещенного-3h-имидазо[4,5-b]пиридина и 3,5-дизамещенного -3h-[1,2,3]триазоло[4,5-b]пиридина как модуляторы протеинкиназ | |
MY172308A (en) | Bicyclic pyrazinone derivatives | |
EA201890449A1 (ru) | Фумагиллиновые гетероциклические соединения и способы их получения и применения | |
EA201491520A1 (ru) | НОВЫЕ СОЕДИНЕНИЯ 3,5-ДИЗАМЕЩЕННОГО-3H-ИМИДАЗО[4,5-b]ПИРИДИНА И 3,5-ДИЗАМЕЩЕННОГО-3H-[1,2,3]ТРИАЗОЛО[4,5-b]ПИРИДИНА КАК МОДУЛЯТОРЫ C-met ПРОТЕИНКИНАЗ | |
MX2017005861A (es) | Metodos para el control transcripcional objetivo en regiones del super mejorador. | |
EA201792103A1 (ru) | Композиции и способы для ингибирования экспрессии генов hif2альфа | |
MX349550B (es) | 1,7-diazacarbazoles y metodos de uso. | |
PH12018502360A1 (en) | 2-anilinopyrimidine derivatives as therapeutic agents for treatment of brain cancers | |
AU2013260056A8 (en) | Compounds with TRPV4 activity, compositions and associated methods thereof | |
MX2015012720A (es) | Sales basicas de adicion de nitroxolina y usos de las mismas. | |
MX2016004212A (es) | Inhibidor de tor cinasa en la prevencion o tratamiento de cancer caracterizado por mutaciones genicas. | |
MX2018003799A (es) | Nueva composicion oftalmica que contiene rebamipida y metodo para prepararla. |